ProLung, Inc. Announces New Japanese Patent for Diagnosing a Malignant Lung Tumor – ProLung, Inc. In News ProLung, Inc. Announces New Japanese Patent for Diagnosing a Malignant Lung Tumor – ProLung, Inc. SALT... Read More
ProLung, Inc. Announces Appointment of Neil Berkley to its Board of Directors – ProLung, Inc. In News ProLung, Inc. Announces Appointment of Neil Berkley to its Board of Directors – ProLung, Inc. SALT... Read More
Steven C. Eror, President and CEO of ProLung, Inc., featured in PharmaVOICE 2018 Year in Preview – ProLung, Inc. In Awards and Recognition, News ProLung, Inc., the world leader in accurate, non-invasive, and radiation-free predictive analytics for rapid risk... Read More
ProLung, Inc. and Steven C. Eror, President and CEO, honored at the Swedish American Life Science Summit (SALSS) as Rising Star; further highlighted by Forbes.com. In News ProLung, Inc. and Steven C. Eror, President and CEO, were honored at the prestigious Swedish... Read More
ProLung, Inc. and Steven C. Eror, President and CEO, honored at the Swedish American Life Science Summit (SALSS) as Rising Star; further highlighted by Forbes.com – ProLung, Inc. In News ProLung, Inc. and Steven C. Eror, President and CEO, were honored at the prestigious Swedish... Read More
ProLung, Inc. Announces Closing of Private Placement Transaction with Proceeds of $8.2 million In News ProLung, Inc. Announces Closing of Private Placement Transaction with Proceeds of $8.2 million[This article is... Read More
